IPO Watch, April 9 -- Anthem Biosciences Limited has obtained approval from the Securities and Exchange Board of India (SEBI) to launch an initial public offering (IPO). The Bengaluru-based firm submitted its Draft Red Herring Prospectus (DRHP) on December 31, 2024, and received its observation letter on April 3, 2025, as per an update from SEBI on Tuesday.

The company's operations include CRDMO services along with the production and sale of Specialty Ingredients. It provides a broad, integrated, and highly adaptable range of CRDMO services that cover the lifecycles of New Chemical Entities (NCE) and New Biological Entities (NBE).

Additionally, it produces and sells complex specialized fermentation-based Active Pharmaceutical Ingredient...